论文部分内容阅读
目的探讨进行D-二聚体、C-反应蛋白(CRP)检测在老年2型糖尿病合并肺炎诊治中的价值。方法 100例老年2型糖尿病合并社区获得性肺炎患者作为观察组,同时选取同期100例健康体检中的健康老年人作为对照组,观察组在常规治疗基础上给予痰热清注射液联合头孢西丁治疗,治疗后观察其临床疗效,检测两组的D-二聚体、CRP水平,并进行比较。结果观察组患者治疗前D-二聚体、CRP明显高于对照组(P<0.05);治疗后D-二聚体、CRP较治疗前明显下降,差异具有统计学意义(P<0.05)。结论痰热清注射液联合头孢西丁治疗老年2型糖尿病合并社区获得性肺炎,可降低D-二聚体、CRP水平,同时提高疗效,患者症状、体征明显改善,值得推广和应用。
Objective To investigate the value of D-dimer and C-reactive protein (CRP) detection in diagnosis and treatment of elderly type 2 diabetes mellitus complicated with pneumonia. Methods 100 elderly patients with type 2 diabetes mellitus complicated with community-acquired pneumonia were selected as the observation group. At the same time, 100 elderly healthy people were selected as the control group. The observation group was given Tanreqing Injection combined with cefoxitin After treatment, the clinical efficacy was observed. The levels of D-dimer and CRP in both groups were detected and compared. Results Before treatment, the D-dimer and CRP in the observation group were significantly higher than those in the control group (P <0.05). The D-dimer and CRP in the observation group were significantly lower than those before treatment, with statistical significance (P <0.05). Conclusion Tanreqing injection combined with cefoxitin in elderly patients with type 2 diabetes mellitus and community-acquired pneumonia can reduce D-dimer and CRP levels and improve the curative effect. The patients’ symptoms and signs are obviously improved, which is worthy of popularization and application.